Related content

Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

By Lynde Charles  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches

By Langley Richard   Ho Vincent   Lynde Charles   Papp Kim   Poulin Yves   Shear Neil   Toole Jack   Zip Catherine  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 18-25

Springer Publishing Company

Access to resources Recommend Favorite

Scholtz–Dumas psoriasis small plaque bioassay

By Katz Martin   Shaikh Zafar   Maibach Howard I  

Journal of Dermatological Treatment, Vol. 11, Iss. 1, 2000-03 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

The value to patients of reducing lesion severity in plaque psoriasis

By Hauber A. Brett   Gonzalez Juan Marcos   Schenkel Brad   Lofland Jennifer H.   Martin Silas  

Journal of Dermatological Treatment, Vol. 22, Iss. 5, 2011-10 ,pp. : 266-275

Informa Healthcare

Access to resources Recommend Favorite

Oral propylthiouracil for the treatment of resistant plaque psoriasis

By Chowdhury M M U   Marks R  

Journal of Dermatological Treatment, Vol. 12, Iss. 2, 2001-06 ,pp. : 81-85

Informa Healthcare

Access to resources Recommend Favorite